Stephen Baylin

27PUBLICATIONS
277CO-AUTHORS
Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 09, 2026
Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia.

Shibing Tang, Liangyi Zong, Shuyuan Ma

|Mar 04, 2026
Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases.

Akshaya V Annapragada, Zachariah H Foda, Hope Orjuela

|Feb 06, 2026
Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial.

Blair V Landon, Julia L Boland, Andrea E Wahner Hendrickson

|Jan 27, 2026
Epigenetic Instability-Based Metrics in Cell-Free DNA for Early Cancer Detection.

Sara-Jayne Thursby, Zhicheng Jin, Jacob Blum

|Oct 15, 2025
Importance of De Novo Gene Evolution to Emerging Viral Threats: The ORF10 Strain-Restricted Orphan Gene of SARS-CoV-2 Promotes Pathogenesis.

Jeffrey A Haltom, Nidia S Trovao, Joseph W Guarnieri

|Sep 22, 2025
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types.

Dorothy Hallberg, Alice C Eastman, Shashikant Koul

Pageof 5

Frequent Collaborators

6 joint publications

Victor E Velculescu

5 joint publications

Peter Jones

5 joint publications

Robert B Scharpf

5 joint publications

Afshin Beheshti